Page 528 - IJB-10-5

International Journal of Bioprinting 3D model of neurogenesis in Alzheimer’s disease

Authorization number 2428100423) approved all 10. Calió ML, Mosini AC, Marinho DS, et al. Leptin enhances
experimental procedures in this study. adult neurogenesis and reduces pathological features in a
transgenic mouse model of Alzheimer’s disease. Neurobiol.
Consent for publication Dis. 2021;148:105219.
doi: 10.1016/j.nbd.2020.105219
Not applicable.
11. Diaz Brinton R, Ming Wang J. Therapeutic potential of
Availability of data neurogenesis for prevention and recovery from Alzheimer’s
disease: allopregnanolone as a proof of concept neurogenic
Data are available from the corresponding authors upon agent. Curr Alzheimer Res. 2006;3(3):185-190.
reasonable request. doi: 10.2174/156720506777632817
12. Sotthibundhu A, Li Q-X, Thangnipon W, Coulson EJ.
References Aβ1–42 stimulates adult SVZ neurogenesis through the p75
neurotrophin receptor. Neurobiol Aging. 2009;30(12):1975-1985.
1. Moreno-Jiménez EP, Flor-García M, Terreros-Roncal J, doi: 10.1016/j.neurobiolaging.2008.02.004
et al. Adult hippocampal neurogenesis is abundant in
neurologically healthy subjects and drops sharply in patients 13. Bernabeu-Zornoza A, Coronel R, Palmer C, Monteagudo
with Alzheimer’s disease. Nat Med. 2019;25(4):554-560. M, Zambrano A, Liste I. Physiological and pathological
doi: 10.1038/s41591-019-0375-9 effects of amyloid-β species in neural stem cell biology.
Neural Regen Res. 2019;14(12):2035-2042.
2. Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. doi: 10.4103/1673-5374.262571
J Physiol Rev. 2001;81(2):741-766.
doi: 10.1152/physrev.2001.81.2.741 14. Walus K, Beyer S, Willerth SM. Three-dimensional
bioprinting healthy and diseased models of the brain
3. Li Puma DD, Piacentini R, Grassi C. Does impairment tissue using stem cells. Curr Opin Biomed Eng. 2020;
of adult neurogenesis contribute to pathophysiology of 14:25-33.
Alzheimer’s disease? A still open question. J Front Mol doi: 10.1016/j.cobme.2020.03.002
Neurosci. 2021;13:578211.
doi: 10.3389/fnmol.2020.578211 15. de Melo BAG, Jodat YA, Cruz EM, Benincasa JC, Shin SR,
Porcionatto MA. Strategies to use fibrinogen as bioink for
4. Kim HS, Shin SM, Kim S, Nam Y, Yoo A, Moon M. 3D bioprinting fibrin-based soft and hard tissues. Acta
Relationship between adult subventricular neurogenesis Biomater. 2020;117:60-76.
and Alzheimer’s disease: pathologic roles and therapeutic doi: 10.1016/j.actbio.2020.09.024
implications. Front Aging Neurosci. 2022;14:1002281.
doi: 10.3389/fnagi.2022.1002281 16. de Melo BAG, Benincasa JC, Cruz EM, Maricato JT,
Porcionatto MA. 3D culture models to study SARS-CoV-2
5. Selkoe DJ. Alzheimer’s disease. Cold Spring Harb Perspect infectivity and antiviral candidates: From spheroids to
Biol. 2011;3:a004457. bioprinting. Biomed J. 2021;44(1):31-42.
doi: 10.1101/cshperspect.a004457 doi: 10.1016/j.bj.2020.11.009
6. Culig L, Chu X, Bohr VA. Neurogenesis in aging and 17. Cruz EM, Machado LS, Zamproni LN, et al. A gelatin
age-related neurodegenerative diseases. Ageing Res Rev. methacrylate-based hydrogel as a potential bioink for 3D
2022;78:101636. bioprinting and neuronal differentiation. Pharmaceutics.
doi: 10.1016/j.arr.2022.101636 2023;15(2):627.
7. Scopa C, Marrocco F, Latina V, et al. Impaired adult doi: 10.3390/pharmaceutics15020627
neurogenesis is an early event in Alzheimer’s disease 18. Knowlton S, Anand S, Shah T, Tasoglu S. Bioprinting
neurodegeneration, mediated by intracellular Aβ oligomers. for neural tissue engineering. Trends Neurosci. 2018;
Cell Death Differ. 2020;27(3):934-948. 41(1):31-46.
doi: 10.1038/s41418-019-0409-3
doi: 10.1016/j.tins.2017.11.001
8. Salles GN, Calió ML, Afewerki S, et al. Prolonged drug-releasing 19. Cadena M, Ning L, King A, et al. 3D bioprinting of neural
fibers attenuate Alzheimer’s disease-like pathogenesis. ACS tissues. Adv Healthc Mater. 2021;10(15):2001600.
Appl Mater Interfaces. 2018;10(43):36693-36702. doi: 10.1002/adhm.202001600
doi: 10.1021/acsami.8b12649
20. Parra-Cantu C, Li W, Quiñones-Hinojosa A, Zhang YS.
9. Salles GN, Calió ML, Hölscher C, Pacheco-Soares C,
Porcionatto M, Lobo AO. Neuroprotective and restorative 3D bioprinting of Glioblastoma model. J 3D Print Med.
properties of the GLP-1/GIP dual agonist DA-JC1 compared 2020;4(2):113-125.
with a GLP-1 single agonist in Alzheimer’s disease. doi: 10.2217/3dp-2019-0027
Neuropharmacology. 2020;162:107813. 21. Gao T, Gillispie GJ, Copus JS, et al. Optimization of gelatin–
doi: 10.1016/j.neuropharm.2019.107813 alginate composite bioink printability using rheological

Volume 10 Issue 5 (2024) 520 doi: 10.36922/ijb.3751